Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.
Lord Victor Adebowale, chair and co-founder of Visionable, discusses why getting technology design right could be key to avoiding health inequity, especially during the COVID-19 crisis.
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
Sue Johnson Gregory, principal consultant, and Tim Powlson, senior consultant, at Entec Si, discuss how the NHS can recover from the long-term impact of COVID-19.
Clare Vale, Managing Director of Sign Solutions, discusses how COVID-19 has highlighted the need for better access to health services for the Deaf community.
David Goff, MD, PhD, Director, Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute at the National Institutes of Health in the U.S., introduces the work of the organisation and his thoughts on supporting heart and vascular health research.
Researchers found that environmental light shown to affect retention of traumatic memories in flies, suggesting a real possibility of change for trauma survivors.
